Seeking Alpha

Regeneron Pharmaceuticals (REGN) says it's been notified of an unsolicited "mini-tender" offer...

Regeneron Pharmaceuticals (REGN) says it's been notified of an unsolicited "mini-tender" offer by TRC Capital Corporation to purchase up to 1M shares, or approximately 1.06%, of the outstanding float at a price of $161.25 per share. REGN] recommends that shareholders reject the offer because it's only a "mini-tender," priced below the current market and subject to numerous conditions.
From other sites
Comments (1)
  • Ted Bear
    , contributor
    Comments (651) | Send Message
     
    short and trying to cover?

     

    Good luck with that.......
    4 Jan 2013, 05:31 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs